Skip to main content

Home/ Dr. Goodyear/ Group items tagged psoriasis

Rss Feed Group items tagged

fnfdoc

Psoriasis: Causes, Symptoms, Types & Treatment - Health Blog - 0 views

  •  
    Psoriasis is a chronic skin condition that accelerates the rate at which your skin cells grow. An effective method to treat psoriasis is phototherapy or light therapy.
  •  
    Psoriasis is an auto-immune illness that affects almost three percent of the world's population. People who suffer from psoriasis experience a great deal of skin irritation and discomfort.
SEO Husain

Psoriasis information & treatment - Treat your Psoriasis with Homeopathy at Dr. Batra's - 0 views

  •  
    Psoriasis is an auto-immune chronic condition that affects the growth cycle of skin cells. Treat your Psoriasis with Homeopathy at Dr. Batra's.
Nathan Goodyear

Hypogonadal men with psoriasis benefit from long-term testosterone replacement therapy ... - 0 views

  •  
    only abstract available here, but Testosterone therapy in men with low T found to reduce CRP, weight and lipids in men with psoriasis.
Nathan Goodyear

Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and... - 0 views

  •  
    Abstract: Inflammatory diesease (psoriasis and RA in this study) associated with increased cardiovascular events.
Nathan Goodyear

Association of Psoriasis Severity with Serum Prolactin, Thyroid Hormones, and Cortisol... - 0 views

  •  
    study suggests that PrL, T3 and cortisol may impact psoriasis treatment in positive manner.
Nathan Goodyear

Evaluation of candidal colonization and specific humoral responses against Candida albi... - 0 views

  •  
    higher colonization of candida albicans found in people with psoriasis vs controls.  Higher in oral cultures vs skin.
Nathan Goodyear

Incidence of Candida in psoriasis--a study on the fungal flora of psoriatic patients. -... - 0 views

  •  
    statistically higher candida detected in those with psoriasis vs controls.
Nathan Goodyear

Cure of Psoriasis and Arthritis when Addison's Disease Was Detected - 0 views

  •  
    case study: addison's disease associated with psoriasis.  
Nathan Goodyear

The role of microorganisms in psoriasis. - PubMed - NCBI - 0 views

  •  
    gut bacteria implicated in psoriasis
Nathan Goodyear

Increased prevalence of onychomycosis among psoriatic patients in Israel. - PubMed - NCBI - 0 views

  •  
    higher prevalence of toe nail fungus in those with psoriasis vs controls.
Nathan Goodyear

Effects of a Skin Neuropeptide (Substance P) on Cutaneous Microflora - 0 views

  •  
    substance P from skin flora, i.e. bacillus cereus, implicated in skin disease like psoriasis, acne, rosacea...
Nathan Goodyear

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2607638/pdf/jnma00404-0073.pdf - 0 views

  •  
    gut bacteria implicated in psoriasis.
Nathan Goodyear

Immune Modulation in Multiple Sclerosis Patients Treated with the Pregnancy Hormone Est... - 0 views

  • A beneficial effect of pregnancy on clinical symptoms has been observed in MS and other Th1-mediated autoimmune diseases, including rheumatoid arthritis (RA), psoriasis, uveitis, and thyroiditis
  • In general, Th1 lymphocytes secrete proinflammatory cytokines (e.g., IL-2, IL-12, IFN-γ, and TNF-α) that promote cellular immunity, while Th2 lymphocytes produce anti-inflammatory cytokines (e.g., IL-4, IL-5, IL-6, and IL-10) that promote humoral immunity
  • Th2 cytokines are associated with the down-regulation of Th1 cytokines and may confer protection from Th1-mediated autoimmune diseases
  • ...1 more annotation...
  • During pregnancy, there is a shift from Th1 to Th2 that occurs both locally, at the fetal maternal interface, (23, 24, 25), and systemically
  •  
    MS is in part a Th1 autoimmune disease.  Estriol therapy induces a shift to Th2 through increase in Th10.  Estriol also decreases TNF-alpha cytokine production.
Nathan Goodyear

Blood dehydroepiandrosterone sulphate (DHEAS) levels in pemphigoid/pemphigus and psoria... - 0 views

  •  
    low DHEA found in individuals with autoimmune disease.  The authors conclude that this may contribute to the cause of the disease(s)
Nathan Goodyear

Psoriatic Arthritis and the Complications of Systemic Inflammation (Dec 2014) Townsend ... - 0 views

  •  
    review of natural treatment of psoriatic arthritis.
Nathan Goodyear

Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer ... - 0 views

  • HCQ, doses for long-term use range between 200 and 400 mg per day.
  • Short-term administration of CQ or HCQ rarely causes severe side effects
  • Short-term administration of CQ or HCQ rarely causes severe side effects
  • ...24 more annotations...
  • bone marrow suppression
  • cardiomyopathy
  • irreversible retinal toxicity
  • hypoglycaemia
  • daily doses up to 400 mg of HCQ or 250 mg CQ for several years are considered to carry an acceptable risk for CQ-induced retinopathies, with the exception of individuals of short stature
  • chronic CQ or HCQ therapy be monitored through regular ophthalmic examinations (3–6 month intervals), full blood counts and blood glucose level checks
  • long-term HCQ exposure, skeletal muscle function and tendon reflexes should be monitored for weakness
  • both CQ and HCQ, specific caution is advised in patients suffering from impaired hepatic function (especially when associated with cirrhosis), porphyria, renal disease, epilepsy, psoriasis, glucose-6-phosphate dehydrogenase deficiency and known hypersensitivity to 4-aminoquinoline compounds
  • CQ and HCQ can effectively increase the efficacy of various anti-cancer drugs
  • CQ can prevent the entrapment of protonated chemotherapeutic drugs by buffering the extracellular tumour environment and intracellular acidic spaces
  • This study recommends an adjuvant HCQ dose of 600 mg, twice daily.
  • HCQ addition was shown to produce metabolic stress in the tumours
  • HCQ (400 mg/day)
  • important effects of CQ and HCQ on the tumour microenvironment
  • The main and most studied anti-cancer effect of CQ and HCQ is the inhibition of autophagy
  • the expression levels of TLR9 are higher in hepatocellular carcinoma, oesophageal, lung, breast, gastric and prostate cancer cells as compared with adjacent noncancerous cells, and high expression is often linked with poor prognosis
  • TLR9-mediated activation of the NF-κB signalling pathway and the associated enhanced expression of matrix metalloproteinase-2 (MMP-2), MMP-7 and cyclo-oxygenase 2 mRNA
  • HCQ can activate caspase-3 and modulate the Bcl-2/Bax ratio inducing apoptosis in CLL, B-cell CLL and glioblastoma cells
  • In triple-negative breast cancer, CQ was shown to eliminate cancer stem cells through reduction of the expression of Janus-activated kinase 2 and DNA methyl transferase 1 [106] or through induction of mitochondrial dysfunction, subsequently causing oxidative DNA damage and impaired repair of double-stranded DNA breaks
  • CQ or HCQ would be considered for use in combination with immunomodulation anti-cancer therapies
  • Therapies used in combination with CQ or HCQ include chemotherapeutic drugs, tyrosine kinase inhibitors, various monoclonal antibodies, hormone therapies and radiotherapy
  • Most studies hypothesise that CQ and HCQ could increase the efficacy of other anti-cancer drugs by blocking pro-survival autophagy.
  • daily doses between 400 and 1200 mg for HCQ are safe and well tolerated, but two studies identified 600-mg HCQ daily as the MTD
  • HCQ is often administered twice daily to limit plasma fluctuations and toxicity
1 - 16 of 16
Showing 20 items per page